UBS Group’s Exscientia Plc American Depositary Shares EXAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-92,395
Closed -$451K – 10668
2024
Q3
$451K Buy
92,395
+80,626
+685% +$422K ﹤0.01% 5303
2024
Q2
$60K Buy
11,769
+1,974
+20% +$9.73K ﹤0.01% 6547
2024
Q1
$56K Sell
9,795
-3,273
-25% -$20.3K ﹤0.01% 6462
2023
Q4
$83.8K Buy
13,068
+418
+3% +$2.37K ﹤0.01% 6278
2023
Q3
$57.2K Buy
12,650
+6,802
+116% +$44K ﹤0.01% 6212
2023
Q2
$34.6K Sell
5,848
-2,138
-27% -$13.1K ﹤0.01% 6659
2023
Q1
$42.3K Buy
7,986
+878
+12% +$5.96K ﹤0.01% 6572
2022
Q4
$37.9K Buy
7,108
+6,808
+2,269% +$43K ﹤0.01% 7019
2022
Q3
$2K Sell
300
-330
-52% -$3.33K ﹤0.01% 9808
2022
Q2
$7K Buy
630
+230
+58% +$2.74K ﹤0.01% 8556
2022
Q1
$6K Sell
400
-12,119
-97% -$207K ﹤0.01% 9016
2021
Q4
$248K Buy
+12,519
New +$263K ﹤0.01% 5503

Other funds holding EXAI

UBS Group's EXAI Position: Q4 2024 in Review

UBS Group sold out of Exscientia Plc American Depositary Shares (EXAI) in Q4 2024, closing a stake of 92,395 shares — an estimated $451K sold.

UBS Group first reported a position in EXAI in Q4 2021 and held it in 12 quarters. The position peaked at $451K in Q3 2024. 1 fund tracked by Wall St. Rank holds EXAI as of Q4 2024.

  • UBS Group reported no remaining Exscientia Plc American Depositary Shares position as of Q4 2024 after selling out during the quarter.
  • UBS Group sold 92,395 Exscientia Plc American Depositary Shares shares in Q4 2024, an estimated $451K.
  • UBS Group first reported a position in Exscientia Plc American Depositary Shares in Q4 2021 and held it in 12 quarters.
  • UBS Group's Exscientia Plc American Depositary Shares position peaked at $451K in Q3 2024.
  • 1 fund tracked by Wall St. Rank held Exscientia Plc American Depositary Shares as of Q4 2024.

Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.